Anjana Bhardwaj

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 4

Top Topics

Lymph Node Metastasis

Acute Coronary Syndrome

Transcription Factor

Top Venues

Breast cancer research : BCR

Breast cancer research and treatment

University of Texas MD Anderson Cancer Center

Post Graduate Institute of Medical Education and Research (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Texas MD Anderson Cancer Center Dec 03 2002

United States

Assistant Professor :: Breast Surgical Oncology

Education History

Post Graduate Institute of Medical Education and Research

India

PHD :: Biophysics

Publications

Anjana Bhardwaj, Matthew D Embury, Raniv D Rojo, Constance Albarracin, Isabelle Bedrosian
Efficacy of fluvastatin and aspirin for prevention of hormonally insensitive breast cancer. Breast cancer research and treatment 187 (2) (2021)
Anjana Bhardwaj, Abhishek Sohni, Chih-Hong Lou, Karel De Gendt, Fanmao Zhang, Eunah Kim, Subbarayalu Panneerdoss, Waikin Chan, Stefanie Kerkhofs, Frank Claessens, Sarah Kimmins, Manjeet K Rao, Marvin L Meistrich, Miles F Wilkinson
Concordant Androgen-Regulated Expression of Divergent Rhox5 Promoters in Sertoli Cells. Endocrinology 163 (1) (2021)
Zhenlin Ju, Anjana Bhardwaj, Matthew D Embury, Harpreet Singh, Preethi H Gunaratne, Isabelle Bedrosian, Jing Wang
Integrative Analyses of Multilevel Omics Reveal Preneoplastic Breast to Possess a Molecular Landscape That is Globally Shared with Invasive Basal-Like Breast Cancer (Running Title: Molecular Landscape of Basal-Like Breast Cancer Progression). Cancers 12 (3) (2020)
Anjana Bhardwaj, Harpreet Singh, Celestine Marie Trinidad, Constance T Albarracin, Kelly K Hunt, Isabelle Bedrosian
The isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer. Breast cancer research : BCR 20 (1) (2018)